According to the current analysis of Reports and Data, the global Hemostasis Analyzers market was valued at USD 2,829.2 Million in 2018 and is expected to reach USD 6,304.1 million by the year 2026, at a CAGR of 10.4 percent.
The growing incidence and large economic burden of blood-related diseases and the rise in healthcare spending have resulted in the increased use of coagulation analyzers.
The increasing frequency of blood clotting disorders, coupled with increasing incidences of excessive blood loss in individuals during medical procedures are key factors boosting the growth of the global hemostasis analyzers market. Moreover, growing awareness regarding hemostasis among individuals in emerging economies, and technological advancements in hemostasis analyzers are some of the key factors propelling market growth in the industry.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Some key highlights of the report:
- Growing geriatric population and increased healthcare spending are some of the factors that support the growth of hemostasis analyzers market
- North America regional segment accounts for the largest share of 34.3% of the global Hemostasis Analyzers market and is expected to continue the trend over the forecast years. The factors that drive the growth of this segment are developed healthcare infrastructure, growing research and development activities, and increasing prevalence of hemostasis disorders in the region
- Mechanical hemostasis analyzers market is expected to witness significant growth market share due to its low cost and high accuracy
- Development of fully automated hemostasis analyzers provides a number of opportunities for emerging players. For instance, Symantec in 2014 launched Automated Blood Coagulation Hemostasis Analyzers CS-2500 that employs the multi-wavelength transmitted light detection system
Key Players covered in this report are
Siemens Healthcare, Thermo Fisher Scientific, Instrumentation Laboratory Werfen Group, Sysmex Corporation, Roche Diagnostics, and Diagnostica Stago, among others
Product (Revenue, USD Million; Volume, Kilo Tons; 2016–2026)
- Analyzer for Point-of-care testing
- Clinical laboratory analyzer
- Consumables
- Reagents
- Standards, Controls, and Calibration
- Systems
- Automated Systems
- Semi-Automated Systems
- Manual
Test Type (Revenue, USD Million; Volume, Kilo Tons; 2016–2026)
- Prothrombin Time
- Fibrinogen
- Activated partial Thromboplastin Time
- Activated Clotting Time
- D Dimer
- Platelet Function
- Anti-factor Xa
- Heparin Protamine response Test for ACT
- Other Coagulation Tests
Technology Type (Revenue, USD Million; Volume, Kilo Tons; 2016–2026)
- Mechanical
- Optical
- Electrochemical
- Other Technologies
End Use (Revenue, USD Million; Volume, Kilo Tons; 2016–2026)
- Diagnostic Centers
- Hospitals
- Research Institutes
- Other end users
Key Regional Markets Studied in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2208
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
